Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 16, 2009 - Issue 2
137
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Excessive fibrinolysis in AL-amyloidosis is induced by urokinae-type plasminogen activator from bone marrow plasma cells

, , , , , , , & show all
Pages 89-93 | Published online: 13 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ryoichi Takahashi, Kenjiro Ono, Tokuhei Ikeda, Akio Akagi, Daisuke Noto, Ichiro Nozaki, Kenji Sakai, Hidesaku Asakura, Kazuo Iwasa & Masahito Yamada. (2012) Coagulation and fibrinolysis abnormalities in familial amyloid polyneuropathy. Amyloid 19:3, pages 129-132.
Read now
Norihiro Suga, Naoto Miura, Wataru Kitagawa, Hiroyuki Morita, Shogo Banno & Hirokazu Imai. (2012) Differential diagnosis of localized and systemic amyloidosis based on coagulation and fibrinolysis parameters. Amyloid 19:2, pages 61-65.
Read now

Articles from other publishers (19)

Søren Thorgaard Bønløkke, Christian Fenger-Eriksen, Hans Beier Ommen & Anne-Mette Hvas. (2023) Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma. Blood Advances 7:22, pages 7056-7066.
Crossref
Irina G. Rekhtina, Victoria A. Khyshova, Nadezhda I. Zozulya, Valentina N. Dvirnyk & Larisa P. Mendeleyeva. (2023) Hemostasis disorders in patients with systemic AL-amyloidosis. Terapevticheskii arkhiv 95:9, pages 746-750.
Crossref
Chihiro Shimazaki, Saori Matsui‐Maegawa, Yayoi Kimoto‐Matsumura, Saeko Ota‐Kuwabara, Daisuke Ide, Shin‐ichi Fuchida & Mayumi Hatsuse. (2023) The serum level of plasmin‐alpha2 plasmin inhibitor complex ( PIC ) is useful for differentiating cardiac light chain amyloidosis from transthyretin amyloidosis . British Journal of Haematology.
Crossref
Mitsuhiro UCHIBA. (2023) α<sub>2</sub>-antiplasminα<sub>2</sub>-アンチプラスミン. Japanese Journal of Thrombosis and Hemostasis 34:3, pages 299-303.
Crossref
José Pardos-Gea, Vicente Cortina, Joana Rita Marques-Soares, Fernanda Martínez & Merche Gironella. (2023) Severe bleeding diathesis as onset of light-chain amyloidosis: combined excessive fibrinolysis and acquired von Willebrand disease in a young patient. Blood Coagulation & Fibrinolysis 34:1, pages 79-81.
Crossref
Laura Acquasaliente & Vincenzo De Filippis. (2022) The Role of Proteolysis in Amyloidosis. International Journal of Molecular Sciences 24:1, pages 699.
Crossref
Ya-juan Gao, Kai-ni Shen, Long Chang, Jun Feng, Yue-ying Mao, Lu Zhang, Xin-xin Cao, Dao-bin Zhou & Jian Li. (2022) Prevalence, clinical characteristics and treatment outcome of factor X deficiency in a consecutive cohort of primary light-chain amyloidosis. Leukemia Research 120, pages 106917.
Crossref
Qijie Ran, Dehong Xu, Qi Wang & Dongsheng Wang. (2022) Hypermethylation of the Promoter Region of miR-23 Enhances the Metastasis and Proliferation of Multiple Myeloma Cells via the Aberrant Expression of uPA. Frontiers in Oncology 12.
Crossref
Simone A. Brysland, Muhammad Gohar Maqbool, Dipti Talaulikar & Elizabeth E. Gardiner. 2022.
Filipa Bezerra, Christoph Niemietz, Hartmut H. J. Schmidt, Andree Zibert, Shuling Guo, Brett P. Monia, Paula Gonçalves, Maria João Saraiva & Maria Rosário Almeida. (2021) In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin Proteolysis. International Journal of Molecular Sciences 22:17, pages 9488.
Crossref
Søren Thorgaard Bønløkke, Hans Beier Ommen & Anne-Mette Hvas. (2021) Altered Fibrinolysis in Hematological Malignances. Seminars in Thrombosis and Hemostasis 47:05, pages 569-580.
Crossref
Filipa Bezerra, Maria João Saraiva & Maria Rosário Almeida. (2020) Modulation of the Mechanisms Driving Transthyretin Amyloidosis. Frontiers in Molecular Neuroscience 13.
Crossref
Masahisa Arahata, Hiroyuki Takamatsu, Eriko Morishita, Yasuko Kadohira, Shinya Yamada, Akitada Ichinose & Hidesaku Asakura. (2020) Coagulation and fibrinolytic features in AL amyloidosis with abnormal bleeding and usefulness of tranexamic acid. International Journal of Hematology 111:4, pages 550-558.
Crossref
Anita Pudusseri, Vaishali Sanchorawala, J. Mark Sloan, Katherine M. Bever, Gheorghe Doros, Shivangi Kataria & Shayna Sarosiek. (2019) Prevalence and prognostic value of D‐dimer elevation in patients with AL amyloidosis. American Journal of Hematology 94:10, pages 1098-1103.
Crossref
Kanji Miyazaki & Kenshi Suzuki. (2018) Elevation of Plasmin-α2-plasmin Inhibitor Complexes in Patients with AL Amyloidosis. Internal Medicine 57:6, pages 775-776.
Crossref
Kazuya Ishiguro, Toshiaki Hayashi, Yoshihiro Yokoyama, Yuka Aoki, Kei Onodera, Hiroshi Ikeda, Tadao Ishida & Hiroshi Nakase. (2018) Elevation of Plasmin-α2-plasmin Inhibitor Complex Predicts the Diagnosis of Systemic AL Amyloidosis in Patients with Monoclonal Protein. Internal Medicine 57:6, pages 783-788.
Crossref
Joseph J. Shatzel, Robyn Scherber & Thomas G. DeLoughery. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 1263 1289 .
Christina Dicke, Sonja Schneppenheim, Katharina Holstein, Brigitte Spath, Carsten Bokemeyer, Rita Dittmer, Ulrich Budde & Florian Langer. (2016) Distinct mechanisms account for acquired von Willebrand syndrome in plasma cell dyscrasias. Annals of Hematology 95:6, pages 945-957.
Crossref
Mitsuhiro UCHIBA, Hiroyuki HATA, Takahisa IMAMURA & Yukio ANDO. (2010) AL amyloidosis and abnormalities of fibrinolysis. Japanese Journal of Thrombosis and Hemostasis 21:1, pages 9-15.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.